Posted by Michael Wonder on 05 Dec 2025
New data on drug approvals and reimbursement recommendations in Canada
27 November 2025 - We have published new data about Canada’s pharmaceutical landscape, including data about drug submissions filed with Health Canada for regulatory review and submissions filed with our Drug Reimbursement Review program to undergo the health technology assessment process.
Our recently established Data Systems and Analytics program compiled the data in collaboration with partners within the pharmaceutical sector. This comprehensive overview provides governments, system leaders, patient organisations, researchers, and other interested parties with authoritative insights into the performance and trends of the drug system in Canada.
